ArticleBlood2018

Scarfò I, Ormhøj M, Frigault MJ, et al. Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.